Illumina (ILMN) agrees to acquire Verinata Health, a provider of non-invasive tests for the...

|By:, SA News Editor

Illumina (ILMN) agrees to acquire Verinata Health, a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for $350M upfront and as much as $100M in milestone payments through 2015. Illumina expects the deal to dilute its EPS by $0.20 in 2013 and become accretive from next year. (PR)